Bioreactors and Fermenters Market Report 2026

The bioreactors and fermenters market size has grown rapidly in recent years. It will grow from $4.69 billion in 2025 to $5.35 billion in 2026 at a compound annual growth rate (CAGR) of 14.2%. The growth in the historic period can be attributed to expansion of biopharmaceutical manufacturing capacity, increasing use of microbial fermentation processes, growth in academic and research bioprocess studies, rising demand for biologics production, improvements in stainless steel bioreactor design.

The bioreactors and fermenters market size is expected to see rapid growth in the next few years. It will grow to $8.44 billion in 2030 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to increasing investments in biologics and biosimilars, rising adoption of continuous manufacturing, expansion of cell and gene therapy production, growing focus on flexible bioprocessing facilities, increasing demand for cost-efficient bioreactor systems. Major trends in the forecast period include increasing adoption of single-use bioreactor systems, rising demand for scalable bioprocessing platforms, growing integration of automated process controls, expansion of continuous bioprocessing methods, enhanced focus on contamination control and sterility.

The growth of the bioreactors and fermenters market is expected to be driven by increasing investments in biotechnology. Biotechnology investment refers to the allocation of financial resources, such as capital or funding, into companies, projects, or ventures within the biotechnology sector. This surge in investment is driven by the rising demand for innovative healthcare solutions and advancements in genetic engineering. Biotechnology funding plays a crucial role in advancing biotechnological processes and accelerating biopharmaceutical production by supporting R&D efforts to improve bioreactor and fermenter technologies. Additionally, it aids in scaling up and commercializing these technologies, facilitating their adoption in industrial biomanufacturing settings. For example, in August 2024, the UK Biotech Financing Report published by the BioIndustry Association (BIA) revealed that the UK biotech sector experienced significant financial growth, with $2.49 billion (£1.98 billion) raised in Q1 and Q2 2024 - surpassing the total raised in 2023, which was $2.25 billion (£1.8 billion). As a result, the rise in biotechnology investments is driving the expansion of the bioreactors and fermenters market.

Leading companies in the bioreactors and fermenters market are leveraging innovation to enhance profitability by developing advanced technological solutions. Next-Gen bioreactor remote monitoring and control software represent one such innovation, providing specialized computer programs or systems designed to oversee and manage bioreactors and fermenters remotely. For example, The Cultivated B GmbH introduced AUXO V software in November 2023, offering real-time monitoring and personalized interfaces accessible remotely via phone and web-based platforms. This next-generation software enables direct or remote control of bioprocesses, ensuring 24/7 monitoring for prompt intervention and automated processes to optimize workforce allocation.

In August 2024, Zydus Lifesciences Limited, a pharmaceutical company based in India, acquired a 50% stake in Sterling Biotech Ltd. for an undisclosed sum. This joint venture aims to establish a state-of-the-art facility for producing fermented animal-free protein, targeting global markets. Sterling Biotech Ltd., an India-based biotechnology company, specializes in the development of innovative fermentation technologies.

Major companies operating in the bioreactors and fermenters market are Thermo Fisher Scientific Inc, Sartorius AG, Danaher Corporation, GE Healthcare, Eppendorf AG, Getinge AB, ZETA Holding, Pierre Guerin SAS, Parr Instrument Company, PBS Biotech, Bioengineering AG, Finesse Solutions, Infors AG, Synthecon Inc, Cellexus Ltd, Scigenics Pvt Ltd, Shanghai Bailun Biological Technology, Zhengzhou Laboao Instrument Equipment, Solaris Biotechnology Srl, Electrolab Biotech Ltd, BBI Biotech GmbH, Distek Inc.

North America was the largest region in the bioreactors and fermenters market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the bioreactors and fermenters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the bioreactors and fermenters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The bioreactors and fermenters market consists of sales of stirred-tank bioreactors, batch bioreactors, stirred-tank bioreactors, photobioreactors, and anaerobic fermenters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.